Matinas BioPharma Has Received A Notice Of Allowance For A U.S. Patent Titled "ENCOCHLEATED ANTIFUNGAL COMPOUNDS FOR CENTRAL NERVOUS SYSTEM DELIVERY AND TREATMENT OF CRYPTOCOCCUS INFECTIONS".

Benzinga Newsdesk www.benzinga.com Neutral 94.1%

Neg 0% Neu 94.1% Pos 0%

https://x.com/PatentGrants/status/2090166066538512778

https://patentcenter.uspto.gov/applications/18767226/ifw/docs

Comments

No comments yet. Be the first!